Henry Couture, 20-Year Medical Device Quality Professional, Joins CytoVeris as Director of Quality
Share Article
Medical technology company driven by the mission to elevate the quality of cancer care through AI-driven optical-guided surgical tools appoints Director of Quality to lead quality system management initiatives during critical time of growth FARMINGTON, Conn. (PRWEB) May 04, 2021
CytoVeris Inc., an emerging company formed with the vision of harnessing advanced technology and real-time AI solutions to enhance the quality of surgical oncology and improve patient care, today announced that Henry Couture has joined the company as Director of Quality. Mr. Couture has an extensive background with over 20 years of experience leading quality and safety initiatives. As Director of Quality, Mr. Couture will further develop CytoVeris’ quality system and ensure compliance as the company readies itself for FDA app
CytoVeris Announces Extension & Expansion of Research Collaboration with Yale University & Smilow Cancer Center
Share Article
Collaboration is developing novel AI-driven smart optical imaging technology designed to enhance surgical guidance capabilities and enable complete tumor excision for breast cancer patients FARMINGTON, Conn. (PRWEB) March 16, 2021
CytoVeris Inc., a medical technology company improving the quality of cancer care through smart optical imaging and surgical guidance technology, today announced the extension of the Company’s research partnership with Yale University. The collaboration continues to build and validate an AI-driven ‘smart’ algorithm which serves as the foundation for optical-based guided tools designed to accurately identify cancerous tissue during surgery.
Matthew McKittrick Named Vice President of Strategic Business Development at CytoVeris
Share Article
Accomplished business strategist and clinical executive with over 12 years of medical device leadership joins medical technology company with mission of elevating the quality of cancer care through convergence of optical-guided surgical tools and machine learning FARMINGTON, Conn. (PRWEB) March 11, 2021
CytoVeris Inc., an emerging company formed with the vision of harnessing advanced technology and real-time AI solutions to enhance the quality of surgical oncology, today announced that Matthew McKittrick has joined join the company as Vice President of Strategic Business Development. Mr. McKittrick has an extensive and proven track record bridging the gap between analytical product management and successful medical device marketing which adds considerable domain expertise to the CytoVeris team and will drive CytoV
Dr. James D’Orta Joins CytoVeris as Chief Medical Officer
Share Article
Accomplished physician, executive, and entrepreneur with over 25 years of clinical and entrepreneurial experience to join biotechnology company in mission to enhance the surgical outcomes of breast cancer patients FARMINGTON, Conn. (PRWEB) January 27, 2021 CytoVeris Inc., an emerging company formed with the vision to change the paradigm in cancer surgery through the introduction of optical-based “guided surgical tools”, today announced that James A. D’Orta, MD, will join the company as Chief Medical Officer. Dr. D’Orta contributes extensive clinical, business, and medical device leadership experience and brings to CytoVeris a successful history providing strategic medical oversight while positioning companies for long-term success.